Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Corporate News
Corporate Performance
Executive Activities
Government
Military
Email
Stock Market
Legal
Internet Media, Content & Design
Table bottom

Pharmaceuticals & Drug Approval
ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a...
CNW Group, 8:28pm ET



ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) has approved Juluca®, indicated as a...
PR Newswire, 7:53pm ET

LONDON, November 22, 2017 /PRNewswire/ -- ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug...
PR Newswire Europe, 7:43pm ET

U.S. Stem Cell, Inc. (OTC: USRM), a leader in development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today responded to the recently-announced Food and Drug...
BusinessWire, 5:08pm ET

SUNRISE, FL / ACCESSWIRE / November 21, 2017 / U.S. Stem Cell, Inc. (OTCQB: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today responded to the recently...
ACCESSWIRE, 9:08am ET

"Herpes is one of those virus that's just amazing at evading our immune system," says Harvey M. Friedman, a professor at the University of Pennsylvania School of Medicine. [1] [2] How does the virus do it? His team discovered that HSV produces a...
PR Newswire, 8:43am ET

US WorldMeds today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review of the New Drug Application (NDA) for lofexidine, an investigational product to mitigate symptoms associated with opioid...
PR Newswire, 8:13am ET

Updated Results of Phase 2 Study of ZX008 in Lennox Gastaut Syndrome to be Presented Data Demonstrating Disease Burden and Negative Impact on Quality of Life of Patients and Families Will Also be Presented Zogenix, Inc....
GlobeNewswire, 8:08am ET

With cancer care costs projected to increase 32% from 2010 to 2020, researchers are working to determine the main drivers of costs for treating breast cancer. Breast cancer accounted for the highest proportion (13%) of the $124.6 billion in...
PR Newswire, 11:18am ET

Akrimax Pharmaceuticals, LLC. (US), AstraZeneca (UK), Cutting Edge Laser Technologies (US), Linline Medical Systems (France), Novartis AG (Switzerland), Pfizer Inc. (US), Pierre Fabre (US) and Quanta System S.p.A. (Italy) are some of the...
ABNewswire, 10:48am ET

ArQule, Inc. (Nasdaq: ARQL) today announced dosing of the initial patients in a registrational trial with its FGFR inhibitor, derazantinib (ARQ 087) in FGFR2 fusion driven second-line intrahepatic Cholangiocarcinoma (iCCA)....
BusinessWire, 7:08am ET

STOCKHOLM, Nov. 21, 2017 /PRNewswire/ -- Business operations Significant events July-September 2017 Important events after the end of the period Financial information Third quarter (July-September 2017)...
PR Newswire Europe, 2:53am ET

Business operations Significant events July-September 2017 -- NeuroVive received positive feedback from the European Medicines Agency (EMA) regarding the NeuroSTAT development plan. -- NeuroVive signed a private placement...
PR Newswire, 2:48am ET

Healthy Ones partnered with Inserra Supermarkets ShopRites to show its support for ongoing diabetes research and prevention. Inserra Supermarkets ShopRites hosted a special presentation at its Ramsey, New Jersey, store where Healthy Ones...
GlobeNewswire, 10:08am ET

GOLDEN, CO / ACCESSWIRE / November 21, 2017 / Vitro Diagnostics, Inc. (OTC PINK: VODG), dba Vitro Biopharma, announced the filing of a USPTO patent application regarding a novel stem cell line and its application to treatment of a variety of...
ACCESSWIRE, 9:38am ET

At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life Sciences ("GE") held a strategic partnership signing ceremony. The strategic partnership agreement is aimed at...
PR Newswire Europe, 8:38am ET

At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life Sciences ("GE") held a strategic partnership signing ceremony. The strategic partnership agreement is aimed at...
PR Newswire, 8:08am ET

At the 5th Canton Nucleic Acids Forum (CNAF) in Guangzhou, China, Guangzhou RiboBio Co., Ltd. ("RiboBio") and GE Healthcare Life Sciences ("GE") held a strategic partnership signing ceremony. The strategic partnership agreement is aimed at...
CNW Group, 8:08am ET

Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the Company's Prior Approval Supplement (PAS) for Bevyxxa(R) (betrixaban) to allow the agency time to...
GlobeNewswire, 6:28pm ET

Janssen Therapeutics, Division of Janssen Products, LP (Janssen), today announced that the U.S. Food and Drug Administration (FDA) has approved JULUCA®, the first, complete, single-pill, two-drug regimen for the treatment of human...
PR Newswire, 6:13pm ET

1-20 of 393
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.